An innovative surgical procedure that uses magnets to control acid reflux disease is effective and has few side effects, a new study shows. The LINX Reflux Management System uses laparoscopic surgery to implant a magnetic ring that helps tighten the esophagus and prevent stomach acid from causing heartburn and other symptoms. Acid reflux is linked […]
Acid reflux treatment company Torax Medical announced Wednesday that it has raised $30 million in a series D round. The company makes an implant that uses magnetized titanium beads to prevent stomach acid from making its way into the esophagus.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mayo Clinic announced Wednesday that its Jacksonville, Florida campus will become one of the first providers in the nation to offer a novel implant procedure to treat acid reflux for those who don’t respond to medication. The product is the LINX Reflux Management System made by Twin Cities-based Torax Medical. The device earned approval from […]
Two months after a regulatory panel recommended the approval of the Linx Reflux Management System, the U.S. Food and Drug Administration approved the minimally invasive device developed by Torax Medical of Shoreview, Minnesota to treat acid reflux. In announcing the premarket approval Thursday, the FDA said that Torax will “institute a required training program to […]
A minimally invasive acid reflux treatment may be on its way to the market. Torax Medical, a Minnesota company announced Friday that a U.S. Food and Drug Administration advisory panel has unanimously recommended the approval of its implantable reflux device to the agency. The FDA had asked the panel to review the so-called LINX device […]
Torax Medical, based in Shoreview, Minnesota, has raised $4 million by issuing debt and is seeking another $4 million in funding, according to a recent regulatory filing. It appears that the company, which is focused on the minimally invasive treatment of gastroesophageal reflux disease, raised $18 million in 2009, $10 million in 2005 and another […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Torax Medical Inc. has received regulatory approval from the European Union to sell an implantable device that treats patients suffering from acid reflux disease. The company’s Linx device is intended for patients with gastroesophageal reflux disease, which involves stomach juices flowing upward into the esophagus. The disease is caused by defects to the esophageal sphincter […]